Merck’s COVID-19 pill significantly less effective in new analysis
An experimental COVID-19 treatment pill, called molnupiravir and being developed by Merck & Co Inc
An experimental COVID-19 treatment pill, called molnupiravir and being developed by Merck & Co Inc